ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced it will be presenting the largest head-to-head, randomised clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback